Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Update for patients

We recognise that this is a very anxious time for people with diabetes and endocrine disorders.  As of 17 March 2020, the Government’s advice for people with diabetes, and for people taking hydrocortisone, prednisolone or other steroid replacement is to “be particularly stringent in following social distancing measures” to reduce transmission of the coronavirus (COVID-19). This involves reducing the social interaction you have with people.

There are several websites which provide up to date and clear information.  They include:

NHS: https://www.nhs.uk/conditions/coronavirus-covid-19/

The UK Government:      https://www.gov.uk/government/publications/covid-19-guidance-on-social-distancing-and-for-vulnerable-people/guidance-on-social-distancing-for-everyone-in-the-uk-and-protecting-older-people-and-vulnerable-adults

Diabetes UK: https://www.diabetes.org.uk/about_us/news/coronavirus

Society for Endocrinology:  https://www.endocrinology.org/news/item/14050/Coronavirus-advice-statement-for-patients-with-adrenal%2fpituitary-insufficiency

Association of British Clinical Diabetologists:        For Healthcare Professionals

                                                                               For People with Diabetes

Oxford University Hospitals is cancelling all routine Diabetes and Endocrinology appointments at present.  If you are awaiting a Day Case appointment you will be contacted by telephone.  All podiatry patients should attend as planned.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

EASD-Robert Turner Clinical Research Training Course

This interactive and highly successful course returns to the face-to-face format in 3-7 April 2022 for its 18th year.

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.